Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

NCT03492489 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: cemiplimab

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]